Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gram-positive bacterial cell wall is a critical structure for bacterial survival, characterized by a thick peptidoglycan layer containing teichoic and lipoteichoic acids. It lacks an outer membrane, unlike Gram-negative bacteria. This structure is essential for maintaining cell shape, resisting osmotic pressure, and mediating interactions with the host environment. The peptidoglycan layer is a primary target for many antibiotics, and disruption of its synthesis leads to bacterial death. Resistance mechanisms, such as altered penicillin-binding proteins or peptidoglycan precursors, pose significant therapeutic challenges. Targeting the cell wall is a key strategy in combating Gram-positive bacterial infections.
Inhibition of peptidoglycan synthesis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-Positive Bacterial Cell Wall.